LoA Update: Roche's Gazyvaro approval prospects in hairy cell leukaemia increases by 10 points ...

Retrieved on: 2021-05-12 11:26:15

Tags for this article:

Click the tags to see associated articles and topics

LoA Update: Roche's Gazyvaro approval prospects in hairy cell leukaemia increases by 10 points .... View article details on hiswai:

Excerpt

Roche's Gazyvaro (obinutuzumab) has its Likelihood of Approval (LoA) jumping by 10 points in hairy cell leukaemia (HCL) on the heels of the ...

Article found on: www.clinicaltrialsarena.com